Wczesne i odległe wyniki leczenia złośliwego międzybłoniaka opłucnej na podstawie analizy 170 przypadków

作者: Bryl Maciej

DOI:

关键词:

摘要:

参考文章(75)
Jens Benn Sørensen, Stein Sundstrøm, Katharina Perell, Anne-Kathrine Thielsen, Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment Journal of Thoracic Oncology. ,vol. 2, pp. 147- 152 ,(2007) , 10.1097/JTO.0B013E31802F3813
Paul HS Shaw, Roshan Agarwal, WITHDRAWN: Pleurodesis for malignant pleural effusions. Cochrane Database of Systematic Reviews. ,(2013) , 10.1002/14651858.CD002916.PUB3
Lanphear Bp, Buncher Cr, Latent period for malignant mesothelioma of occupational origin Journal of Occupational and Environmental Medicine. ,vol. 34, pp. 718- 721 ,(1992)
K Kuziemski, E Jassem, JM Słomiński, A Drozdowska, Trudności w rozpoznawaniu złośliwego międzybłoniaka opłucnej - opis przypadków Advances in Palliative Medicine (dawniej Polska Medycyna Paliatywna). ,vol. 4, pp. 81- 84 ,(2005)
H. I. Pass, P. Rizzo, M. Carbone, A. Procopio, D. J. Y. Mew, M. Di Muzio, M. Marinetti, A. S. Levine, Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. ,vol. 9, pp. 1781- 1790 ,(1994)
H. E. Robertson, “Endothelioma” of the Pleura The Journal of Cancer Research. ,vol. 8, pp. 317- 375 ,(1924) , 10.1158/JCR.1924.317
Nicholas J. Vogelzang, Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma? Journal of Clinical Oncology. ,vol. 17, pp. 2626- 2627 ,(1999)
Jeremy P. C. Steele, Jonathan Shamash, Marie T. Evans, Nicole H. Gower, Marc D. Tischkowitz, Robin M. Rudd, Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma Journal of Clinical Oncology. ,vol. 18, pp. 3912- 3917 ,(2000) , 10.1200/JCO.2000.18.23.3912
Katharina Leithner, Andreas Leithner, Heimo Clar, Andreas Weinhaeusel, Roman Radl, Peter Krippl, Peter Rehak, Reinhard Windhager, Oskar A Haas, Horst Olschewski, Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40 Orphanet Journal of Rare Diseases. ,vol. 1, pp. 44- 44 ,(2006) , 10.1186/1750-1172-1-44
A P Chahinian, K Antman, M Goutsou, J M Corson, Y Suzuki, C Modeas, J E Herndon, J Aisner, R R Ellison, L Leone, Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. Journal of Clinical Oncology. ,vol. 11, pp. 1559- 1565 ,(1993) , 10.1200/JCO.1993.11.8.1559